Skip to main content
Log in

Hemodynamic factors in the pathogenesis of diabetic nephropathy

  • Übersicht
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

The pathogenesis of the diabetic glomerular lesion is unknown. However, cumulative indirect evidence favors hemodynamic factors associated with the abnormal endocrine environment as the cause of diabetic angiopathy. Experimental evidence suggests that the increased hydrostatic pressures in capillary beds, a hallmark of the early stages of insulin-dependent diabetes, are associated with macromolecular leakage leading to the typical thickening of glomerular capillary basement membrane and increased glomerular mesangial matrix even prior to the occurrence of systemic hypertension. Patients with renal or carotid artery stenosis seem to be protected against diabetic nephropathy and retinopathy on the stenosed side. The first signal of diabetic nephropathy even before deterioration of the renal function is microalbuminuria detected by sensitive methods such as radioimmunoassay. Not only in hypertensive, but even in normotensive diabetic patients with microalbuminuria antihypertensive therapy has been shown to reduce albumin excretion rate and to slow the progression of diabetic nephropathy. Once overt diabetic nephropathy has been established, hypertension is a constant accompaniment of the disease. Thus, hypertension may be a cause as well as a result of diabetic nephropathy. Tight control of blood sugar in close association with antihypertensive treatment reducing blood pressure to a lower normal limit, possibly with agents that specifically decrease glomerular capillary hydraulic pressure are the corner stone in protection against progression of the diabetic angiopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ECF:

extracellular fluid

ESRD:

end-stage renal disease

References

  1. Anderson S, Rennke HG, Brenner BM (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993–2000

    Google Scholar 

  2. Behrendt T, Duane TD (1970) Unilateral complications in diabetic retinopathy. Trans Am Acad Ophth Otol 74:28–32

    Google Scholar 

  3. Bending JJ, Viberti GC, Bilous RW, Keen H (1985) Eight-month correction of hyperglycaemia in insulin-dependent diabetes mellitus is associated with a significant and sustained reduction of urinary albumin excretion rates in patients with microalbuminuria. Diabetes [Suppl 3] 34:69–73

    Google Scholar 

  4. Bending JJ, Dodds R, Keen H, Viberti GC (1986) Lowering protein intake and the progression of diabetic renal failure. Diabetologia 29:516A

    Google Scholar 

  5. Berkman J, Rifkin H (1973) Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): Report of a case. Metabolism 22:715–722

    Google Scholar 

  6. Beyer-Mears A (1986) The polyol pathway, sorbinil and renal dysfunction. Metabolism 35:46–54

    Google Scholar 

  7. Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M (1986) Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293:471–474

    Google Scholar 

  8. Borch-Johnsen K, Kreiner S (1987) Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J 294:1651–1654

    Google Scholar 

  9. Carrie BJ, Myers BD (1980) Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy. Kidney Int 17:669–676

    Google Scholar 

  10. Cohen DL, Dodds R, Viberti GC (1986) Reduction of microalbuminuria and glomerular filtration rate by dietary protein restriction in type I (insulin-dependent) diabetic patients: an effect independent of blood glucose control and arterial pressure changes. Diabetologia 29:528A

    Google Scholar 

  11. Editorial (1987) Provision of renal replacement therapy for diabetic patients in the UK. Lancet II:21–22

  12. Gundersen JHG (1974) Peripheral blood flow and metabolic control in juvenile diabetes. Diabetologia 10:225–231

    Google Scholar 

  13. Harris DCH, Hammond WS, Burke TJ, Schrier RW (1986) Effect of phosphate restriction on proteinuria of streptozotocin, uninephrectomized model of diabetic nephropathy in the rat. Kidney Int 29:319 (Abstract)

    Google Scholar 

  14. Hommel E, Parving HH, Mathiesen E, Edsberg B, Nielsen MD, Giese J (1986) Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 293:467–470

    Google Scholar 

  15. Knowler WC, Bennett PH, Ballintine EJ (1980) Increased incidence of retinopathy in diabetics with elevated blood pressure: a six-year follow-up study in Pima Indians. N Engl J Med 302/12:645–650

    Google Scholar 

  16. Kohner EM, Hamilton AM, Saunders SJ, Sutcliffe BA, Bulpitt CJ (1975) The retinal blood flow in diabetes. Diabetologia 11:27–33

    Google Scholar 

  17. Mathiesen ER, Oxenbell R, Johansen K, Svendsen PA, Deckert T (1984) Incipient nephropathy in type I (insulin-dependent) diabetes. Diabetologia 26:406–410

    Google Scholar 

  18. Mangili R, Bending JJ, Scott G, Viberti GC (1987) Increased red cell Na+/Li+ counter transport activity in insulin-dependent diabetics with clinical nephropathy. Europ J Clin Invest 17:A7 (Abstract)

    Google Scholar 

  19. Marre M, Leblanc H, Suarez L, Guyenne T, Menard J, Passa P (1987) Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 294:1448–1452

    Google Scholar 

  20. Mauer SM, Steffes MW, Azar S, Sandberg SK, Brown DM (1978) The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes 27:738–744

    Google Scholar 

  21. Mogensen CE (1976) Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment. Scand J Clin Lab Invest 36:383–388

    Google Scholar 

  22. Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89–93

    Google Scholar 

  23. Parving HH, Andersen AR, Smidt AM, Svendsen PA (1983) Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet I:1175–1177

    Google Scholar 

  24. Parving HH, Viberti GC, Keen H, Christiansen JS, Lassen NA (1983) Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 32:943–949

    Google Scholar 

  25. Parving HH, Andersen AR, Hommel E, Smidt U (1985) Effects of long-term antihypertensive treatment on kidney function in diabetic nephropathy. Hypertension [Suppl 2] 7:114–117

    Google Scholar 

  26. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA (1987) Effect of antihypertensive treatment on kindey function in diabetic nephropathy. Br Med J 294:1443–1447

    Google Scholar 

  27. Rasch R, Rytter Nörgaard JO (1983) Renal enlargement: comparative autoradiographic studies of3H-thymidine uptake in diabetic and uninephrectomised rats. Diabetologia 25:280–287

    Google Scholar 

  28. Slusher MM (1975) Retinal sparing in diabetic retinopathy. South Med J 68:655–657

    Google Scholar 

  29. Steffes MW, Brown DM, Mauer SM (1978) Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 27:35–41

    Google Scholar 

  30. Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y (1985) Effect of Captopril on heavy proteinuria in azotemic diabetes. N Engl J Med 313:1617–1620

    Google Scholar 

  31. Viberti GC (1979) Early functional and morphological changes in diabetic nephropathy. Clin Nephrol 12:47–53

    Google Scholar 

  32. Viberti GC, Bending JJ (1987) Early diabetic nephropathy: detection and prevention. Necker Seminars, Paris, May 1987

    Google Scholar 

  33. Viberti GC, Wiseman MJ (1986) The kidney in diabetes: significance of the early abnormalities. Clinics Endo Metab 15:753–782

    Google Scholar 

  34. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet I:1430–1432

    Google Scholar 

  35. Viberti GC, Bilous RW, MacKintosh D, Bending JJ, Keen H (1983) Long-term correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. Br Med J 286:598–602

    Google Scholar 

  36. Viberti GC, Keen H, Wiseman MJ (1987) Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. Lancet (submitted)

  37. Walker MG, Hermann J, Murphy R, Patz A (1985) Elevated blood pressure and angiotensin II are associated with accelerated loss of renal function diabetic nephropathy. Am Clim Clin Assoc Trans 97:94–104

    Google Scholar 

  38. Winocour PH, Durrington PN, Ishola M, Anderson DC, Cohen H (1987) Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin-dependent diabetes mellitus. Br Med J 294:1648–1651

    Google Scholar 

  39. Wiseman MJ, Viberti GC, MacKintosh D, Jarrett RJ, Keen H (1984) Glycemia, arterial pressure and microalbuminuria in type I (insulin-dependent) diabetes mellitus. Diabetologia 26:401–405

    Google Scholar 

  40. Wiseman MJ, Saunders AJ, Keen H, Viberti GC (1985) Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 312:617–621

    Google Scholar 

  41. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925–1930

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schrier, R.W., Holzgreve, H. Hemodynamic factors in the pathogenesis of diabetic nephropathy. Klin Wochenschr 66, 325–331 (1988). https://doi.org/10.1007/BF01735788

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01735788

Key words

Navigation